Stonegate Investment Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SFBS
ServisFirst Bancshares
SFBS
|
+$55.6M |
| 2 |
Intel
INTC
|
+$39.4M |
| 3 |
Advanced Micro Devices
AMD
|
+$35.7M |
| 4 |
Amgen
AMGN
|
+$34.4M |
| 5 |
Palo Alto Networks
PANW
|
+$29.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$44.2M |
| 2 |
Kenvue
KVUE
|
+$38.1M |
| 3 |
RTX Corp
RTX
|
+$5.4M |
| 4 |
Southern Company
SO
|
+$4.1M |
| 5 |
Veeva Systems
VEEV
|
+$2.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.45% |
| 2 | Financials | 14.47% |
| 3 | Healthcare | 11.24% |
| 4 | Energy | 9.62% |
| 5 | Consumer Staples | 8.74% |
Similar funds
Stonegate Investment Group's Q2 2024 Portfolio in Review
As of Q2 2024, Stonegate Investment Group held 417 positions worth $3.46B, up 8.5% from $3.19B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Stonegate Investment Group deployed $217M of net new capital in Q2 2024, opening 43 new positions and adding to 202 existing holdings. Its largest new stake was Colgate-Palmolive: 11,690 shares worth $1.13M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was CVS Health, an estimated $44.2M trimmed.
- Stonegate Investment Group's largest Q2 2024 buy was Colgate-Palmolive: 11,690 shares worth $1.13M.
- Stonegate Investment Group added most to ServisFirst Bancshares in Q2 2024, an estimated $55.6M increase.
- Stonegate Investment Group's biggest Q2 2024 reduction was CVS Health, cutting an estimated $44.2M.
- Stonegate Investment Group fully exited Veeva Systems in Q2 2024, selling an estimated $2.7M.
- Stonegate Investment Group's ten largest holdings make up 40% of its $3.46B portfolio in Q2 2024.
- Stonegate Investment Group opened 43 new positions and closed 22 in Q2 2024.
- Stonegate Investment Group's portfolio value rose 8.5% quarter-over-quarter to $3.46B.
Based on Stonegate Investment Group's 13F filing for Q2 2024, filed 2 Aug 2024.